Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Issue of Equity

25 Aug 2021 09:53

RNS Number : 7480J
Amati AIM VCT PLC
25 August 2021
 

Amati AIM VCT plc

25 August 2021

 

Amati AIM VCT plc (the "Company")

Legal Entity Identifier: 213800HAEDBBK9RWCD25

Issue of Equity

The Board of Amati AIM VCT plc (the "Company") is pleased to announce that on 23 August 2021 it allotted 4,158,772 new Ordinary Shares of 5p each in the capital of the Company ("Ordinary Shares") pursuant to the Offer for Subscription launched on 30 July 2021 (the "Offer"). In accordance with the terms and conditions of the Offer, the price at which 4,142,726 new Ordinary Shares were allotted, which was calculated by reference to the net asset value of an Ordinary Share on 19 August 2021, was 219.67p per Ordinary Share (net asset value divided by 0.99 to allow for issue costs of 1.0%) and the price at which 16,046 new Ordinary Shares were allotted, which was calculated by reference to the net asset value of an Ordinary Share on 5 August 2021, was 218.10p per Ordinary Share (net asset value divided by 0.99 to allow for issue costs of 1.0%)

As announced on 4 August 2021, the Offer is fully subscribed and currently closed for new applications unless and until the Board decides to utilise the over-allotment facility, in which case a further announcement will be made.

Applications have been made for the new Ordinary Shares to be admitted to the Official List of the FCA (with a Premium Listing) and to the London Stock Exchange for admission to trading on the main market for listed securities. It is expected that admission will occur and dealing will commence in the new Ordinary Shares on or around 31 August 2021.

As a result of the issue, the total number of Ordinary Shares in issue will be 137,072,218 and the total number of voting rights in the Company will be 137,072,218. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure Guidance and Transparency Rules.

For further information, please contact the investor line at Amati Global Investors on 0131 503 9115 or by email at info@amatiglobal.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEDKPBPFBKKDFB
Date   Source Headline
11th Mar 20223:13 pmRNSNet Asset Value(s)
11th Mar 202211:52 amRNSCompliance with Market Abuse Regulation
4th Mar 20224:16 pmRNSNet Asset Value(s)
2nd Mar 20225:05 pmRNSDirector/PDMR Shareholding
2nd Mar 20224:58 pmRNSIssue of Equity
2nd Mar 20222:00 pmRNSResult of General Meeting
1st Mar 20225:37 pmRNSNet Asset Value(s)
1st Mar 202211:43 amRNSTotal Voting Rights
21st Feb 20224:57 pmRNSTransaction in Own Shares
21st Feb 20228:53 amRNSClose of Offer to Further Applications
18th Feb 20223:34 pmRNSNet Asset Value(s)
14th Feb 20224:06 pmRNSTransaction in Own Shares
14th Feb 20229:27 amRNSUpdate on offer for subscription
11th Feb 20224:41 pmRNSNet Asset Value(s)
7th Feb 20225:25 pmRNSTransaction in Own Shares
7th Feb 20221:15 pmRNSCircular Publication & Notice of General Meeting
4th Feb 20224:00 pmRNSNet Asset Value per Share
2nd Feb 202212:04 pmRNSNet Asset Value(s)
1st Feb 20229:51 amRNSTotal Voting Rights
24th Jan 202212:30 pmRNSTransaction in Own Shares
21st Jan 20226:16 pmRNSNet Asset Value per Share
21st Jan 20222:12 pmRNSTransaction in Own Shares
18th Jan 20221:47 pmRNSPublication of a supplementary Prospectus
18th Jan 202212:49 pmRNSTransaction in Own Shares
17th Jan 20227:00 amRNSNet Asset Value per Share
12th Jan 20221:08 pmRNSTransaction in Own Shares
7th Jan 20226:27 pmRNSNet Asset Value per Share
6th Jan 20221:45 pmRNSTransaction in Own Shares
4th Jan 20225:14 pmRNSNet Asset Value(s)
29th Dec 20217:00 amRNSNet Asset Value(s)
17th Dec 20213:54 pmRNSNet Asset Value(s)
15th Dec 20217:00 amRNSUpdate on Offer for Subscription
13th Dec 20218:43 amRNSNet Asset Value(s)
2nd Dec 20218:03 amRNSNet Asset Value(s)
1st Dec 202111:25 amRNSTotal Voting Rights
30th Nov 20211:04 pmRNSDirector/PDMR Shareholding
26th Nov 20214:09 pmRNSIssue of Equity - DRIS
26th Nov 20212:03 pmRNSPurchase of Own Securities
26th Nov 20211:50 pmRNSNet Asset Value(s)
24th Nov 202110:23 amRNSTransaction in Own Shares
22nd Nov 20219:19 amRNSTransaction in Own Shares
19th Nov 20213:38 pmRNSNet Asset Value(s)
12th Nov 20213:20 pmRNSNet Asset Value(s)
5th Nov 20213:58 pmRNSNet Asset Value(s)
3rd Nov 20219:18 amRNSTransaction in Own Shares
1st Nov 20214:54 pmRNSNet Asset Value(s)
1st Nov 20212:24 pmRNSTransaction in Own Shares
1st Nov 202110:23 amRNSTotal Voting Rights
25th Oct 202110:21 amRNSNet Asset Value(s)
15th Oct 20214:25 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.